Loading...

ENG KOR

KB STAR ETF 로고

홈으로 이동

KOR ENG

ETF Finder

Home Product Lineup ETF Finder Product Details
Domestic
Equity Passive

RISE Healthcare (253280)

Update : 2026.05.06

NAV

16,347KRW

-0.04하락 (-%)

Market Price per share (KRW)

16,330KRW

-50하락 (-0.31%)

※ t-1 last price

trading volume

3,355shares

AUM

KRW 10.6billion

Share it

RISE Healthcare (253280)

Overview Performance Holdings

KEY POINT

Invest in domestic healthcare companies (medical equipment and services, bio, pharmaceutical)

KEY POINT

Invest in selected healthcare companies based on financial conditions among the top 500 companies by market capitalization of the KOSPI and KOSDAQ markets

Basic information

Download trading information

Update : 2026.05.06
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare ETF
(253280) 		FnGuide HealthCare Index 2016.09.23 50,000 10,625,601,708
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 16,330
※ t-1 last price 		16,347 3,355
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%) Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare ETF

(253280) 		FnGuide HealthCare Index
Inception date Creation Unit
2016.09.23 50,000
AUM(0.1 billion) (KRW) Trustee
10,625,601,708 하나은행
Market Price per share (KRW) iNAV per share (KRW)
16,330
※ t-1 last price 		16,347
Trading Volume (shares)
3,355
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%)
Distribution Frequency
Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Index is a market capitalization weighted index. The index selects stocks that satisfy financial and management soundness criteria out of the universe of stocks come under the medical sector in the MKF 500.

View detailed index information

TOP 10 Holdings

Update : 2026-05-06
Rank , Name, proportion table
Rank Name Weight (%)
1 Celltrion 10.91
2 SAMSUNG BIOLOGICS 9.08
3 Alteogen 8.49
4 HLB 8.38
5 SCD 6.66
6 ABL Bio 6.48
7 Yuhan 5.90
8 LCB 5.57
9 HanmiPharm 3.27
10 SKBP 3.17

proportion by sectors

*The proportion of investment stocks

Update : 2026.05.06
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2026-04-30 2026-05-06 25
2025-04-30 2025-05-07 20
2023-04-28 2023-05-03 16
2022-04-29 2022-05-03 60

Performance

performance

excel download

Update : 2026-05-06

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)		 Since
inception
NAV -2.42 -9.24 0.02 18.33 42.08 -2.77 61.42
Benchmark Index -2.48 -9.49 -0.09 18.76 42.31 -2.84 62.64
Outperformance 0.06 0.25 0.11 -0.44 -0.24 0.06 -1.22

daily Performance

excel download

-
search
date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW) Standard Tax Base Price (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2026.05.04 16,330 -0.305하락 16,347.12 -0.028하락 10,358.3
2026.04.30 16,380 -3.305하락 16,351.91 -3.213하락 10,358.47
2026.04.29 16,940 -0.352하락 16,894.76 -0.591하락 10,358.51
2026.04.28 17,000 -2.242하락 16,995.33 -2.008하락 10,358.55
2026.04.27 17,390 2.233상승 17,343.72 1.935상승 10,381.59
2026.04.24 17,010 1.978상승 17,014.47 1.830상승 10,381.72
2026.04.23 16,680 -0.388하락 16,708.55 0.107상승 10,381.76
2026.04.22 16,745 -1.731하락 16,690.66 -2.306하락 10,381.8
2026.04.21 17,040 -2.068하락 17,084.68 -1.672하락 10,381.84
2026.04.20 17,400 -0.486하락 17,375.33 -0.470하락 10,381.89
2026.04.17 17,485 -0.766하락 17,457.51 -0.611하락 10,382.02
2026.04.16 17,620 -0.282하락 17,564.85 -0.298하락 10,381.77
2026.04.15 17,670 5.084상승 17,617.44 4.310상승 10,381.82
2026.04.14 16,815 0.839상승 16,889.4 0.810상승 10,381.86
2026.04.13 16,675 -0.862하락 16,753.6 -0.171하락 10,381.9
2026.04.10 16,820 0.869상승 16,782.41 0.557상승 10,383.31
2026.04.09 16,675 -0.209하락 16,689.34 0.093상승 10,383.35
2026.04.08 16,710 2.452상승 16,673.74 2.314상승 10,383.39
2026.04.07 16,310 -1.806하락 16,296.61 -1.618하락 10,383.45
2026.04.06 16,610 -1.189하락 16,564.76 -1.269하락 10,383.63

Holdings

search
Download holdings data
Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 Celltrion KR7068270008 451 10.91 89,207,800
2 SAMSUNG BIOLOGICS KR7207940008 50 9.08 74,250,000
3 Alteogen KR7196170005 186 8.49 69,378,000
4 HLB KR7028300002 1,125 8.38 68,512,500
5 SCD KR7000250001 133 6.66 54,463,500
6 ABL Bio KR7298380007 400 6.48 53,000,000
7 Yuhan KR7000100008 533 5.9 48,236,500
8 LCB KR7141080002 251 5.57 45,556,500
9 HanmiPharm KR7128940004 60 3.27 26,700,000
10 SKBP KR7326030004 261 3.17 25,917,300
11 PharmaResearch KR7214450009 64 2.65 21,696,000
12 ST Pharm KR7237690003 124 2.33 19,071,200
13 원화예금 KRD010010001 17,393,057 2.13 17,393,057
14 HANALL BIOPHARMA KR7009420001 338 1.91 15,649,400
15 Hugel KR7145020004 51 1.63 13,336,500
16 CLASSYS KR7214150005 206 1.42 11,597,800
17 SKBS KR7302440003 254 1.35 10,998,200
18 Celltrionph KR7068760008 197 1.34 10,953,200
19 Pharmicell KR7005690003 535 1.33 10,833,750
20 L&C BIO KR7290650001 159 1.22 9,985,200
21 CHA Biotech KR7085660009 517 1.07 8,737,300
22 ORUM KR7475830006 91 1.05 8,544,900
23 SEEGENE KR7096530001 307 0.92 7,521,500
24 Hanmi Science KR7008930000 194 0.9 7,381,700
25 GC Biopharma Corp. KR7006280002 53 0.89 7,287,500
26 HK inno.N KR7195940002 136 0.87 7,072,000
27 CHONGKUNDANG KR7185750007 76 0.8 6,543,600
28 DAEWOONG PHARM KR7069620003 43 0.78 6,351,100
29 MedyTox KR7086900008 52 0.67 5,486,000
30 DongKook Pharm KR7086450004 226 0.66 5,367,500
31 ILDONG PHARM KR7249420001 202 0.64 5,241,900
32 HLBPHARMA KR7047920004 267 0.56 4,611,090
33 CUREXO KR7060280005 278 0.55 4,503,600
34 i-SENS KR7099190001 200 0.53 4,360,000
35 Daewoong KR7003090008 188 0.52 4,211,200
36 EuBio KR7206650004 298 0.46 3,787,580
37 ShinpoongPharm KR7019170000 317 0.44 3,626,480
38 DENTIUM KR7145720009 63 0.41 3,326,400
39 Huons Global KR7084110006 52 0.39 3,224,000
40 Binex KR7053030003 276 0.37 3,033,240
41 WONTECH KR7336570007 415 0.37 3,029,500
42 SELVAS AI KR7108860008 227 0.36 2,960,080
43 BioPlus KR7099430001 405 0.29 2,377,350
44 Humedix KR7200670008 57 0.25 2,032,050
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.